Literature DB >> 34086096

Comparison of the retinal vascular network and structure in patients with optic neuritis associated with myelin oligodendrocyte glycoprotein or aquaporin-4 antibodies: an optical coherence tomography angiography study.

Jian Yu1,2,3,4, Yongheng Huang1,2,3,4,5, Lei Zhou6, Jingzi ZhangBao6, Yuan Zong1,2,3,4, Chao Quan7, Min Wang8,9,10,11.   

Abstract

OBJECTIVE: To compare the retinal vascular network and structure of optic neuritis associated with myelin oligodendrocyte glycoprotein antibodies (MOG-ON) or aquaporin-4 antibodies (AQP4-ON).
METHODS: Nineteen patients with MOG-ON (29 eyes), 24 patients with AQP4-ON (43 eyes), and 25 healthy participants (50 eyes) were enrolled. The best-corrected visual acuity (BCVA), mean deviation (MD), retinal nerve fiber layer (RNFL) thickness, parafoveal ganglion cell and inner plexiform layer (GCIPL) thickness, and vessel densities in the peripapillary and parafoveal areas were measured.
RESULTS: The BCVA, RNFL thickness, GCIPL thickness, and vessel densities in the peripapillary and parafoveal areas were significantly decreased in the AQP4-ON and MOG-ON eyes compared with healthy controls (all P < 0.05). There were no significant differences in the MD, RNFL thickness, GCIPL thickness, or vessel densities between the AQP4-ON and MOG-ON eyes (all P > 0.05). However, the BCVA was significantly worse in AQP4-ON eyes than in MOG-ON eyes (P = 0.001). The peripapillary vessel density was significantly correlated with the BCVA and MD in AQP4-ON eyes and with MD in MOG-ON eyes (all P < 0.05).
CONCLUSIONS: MOG-ON and AQP4-ON are associated with severe visual dysfunction, as well as retinal structural and vascular damage. The extent of visual dysfunction was strongly correlated with the peripapillary vessel density. Although we found no significant difference in the MD between MOG-ON and AQP4-ON, which are characterized by comparable vascular and structural damage within the peripapillary and parafoveal areas, the BCVA was worse in AQP4-ON eyes than in MOG-ON eyes.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Aquaporin-4; Myelin oligodendrocyte glycoprotein; Optic neuritis; Optical coherence tomography angiography; Vessel density

Mesh:

Substances:

Year:  2021        PMID: 34086096     DOI: 10.1007/s00415-021-10609-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   6.682


  15 in total

1.  Neurometabolic coupling between neural activity, glucose, and lactate in activated visual cortex.

Authors:  Baowang Li; Ralph D Freeman
Journal:  J Neurochem       Date:  2015-05-29       Impact factor: 5.372

2.  Optic neuritis in neuromyelitis optica.

Authors:  Marc H Levin; Jeffrey L Bennett; A S Verkman
Journal:  Prog Retin Eye Res       Date:  2013-03-30       Impact factor: 21.198

3.  The clinical characteristics of AQP4 antibody positive NMO/SD in a large cohort of Chinese Han patients.

Authors:  Jingzi ZhangBao; Lei Zhou; Xiaoyang Li; Tongjia Cai; Jiahong Lu; Chuanzhen Lu; Chongbo Zhao; Chao Quan
Journal:  J Neuroimmunol       Date:  2016-12-02       Impact factor: 3.478

4.  Peripapillary and Macular Vessel Density in Patients with Primary Open-Angle Glaucoma and Unilateral Visual Field Loss.

Authors:  Adeleh Yarmohammadi; Linda M Zangwill; Patricia Isabel C Manalastas; Nathanael J Fuller; Alberto Diniz-Filho; Luke J Saunders; Min Hee Suh; Kyle Hasenstab; Robert N Weinreb
Journal:  Ophthalmology       Date:  2017-11-22       Impact factor: 12.079

5.  Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disorders.

Authors:  Felix Schmidt; Hanna Zimmermann; Janine Mikolajczak; Frederike C Oertel; Florence Pache; Maria Weinhold; Johann Schinzel; Judith Bellmann-Strobl; Klemens Ruprecht; Friedemann Paul; Alexander U Brandt
Journal:  Mult Scler Relat Disord       Date:  2016-11-20       Impact factor: 4.339

6.  Morphological consequences of myelination in the human retina.

Authors:  T FitzGibbon; Z Nestorovski
Journal:  Exp Eye Res       Date:  1997-12       Impact factor: 3.467

7.  MOG-antibody associated demyelinating disease of the CNS: A clinical and pathological study in Chinese Han patients.

Authors:  Lei Zhou; Yongheng Huang; Haiqing Li; Jie Fan; Jingzi Zhangbao; Hai Yu; Yuxin Li; Jiahong Lu; Chongbo Zhao; Chuanzhen Lu; Min Wang; Chao Quan
Journal:  J Neuroimmunol       Date:  2017-01-12       Impact factor: 3.478

8.  Recovery from optic neuritis attack in neuromyelitis optica spectrum disorder and multiple sclerosis.

Authors:  Hiroki Masuda; Masahiro Mori; Akiyuki Uzawa; Mayumi Muto; Tomohiko Uchida; Ryohei Ohtani; Ryutaro Akiba; Hirotaka Yokouchi; Shuichi Yamamoto; Satoshi Kuwabara
Journal:  J Neurol Sci       Date:  2016-06-17       Impact factor: 3.181

9.  Optical coherence tomography angiography of optic nerve head and parafovea in multiple sclerosis.

Authors:  Xiaogang Wang; Yali Jia; Rebecca Spain; Benjamin Potsaid; Jonathan J Liu; Bernhard Baumann; Joachim Hornegger; James G Fujimoto; Qiang Wu; David Huang
Journal:  Br J Ophthalmol       Date:  2014-05-15       Impact factor: 4.638

10.  Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis.

Authors:  Sudarshini Ramanathan; Stephen W Reddel; Andrew Henderson; John D E Parratt; Michael Barnett; Prudence N Gatt; Vera Merheb; Raani-Yogeeta Anusuiya Kumaran; Karrnan Pathmanandavel; Nese Sinmaz; Mahtab Ghadiri; Con Yiannikas; Steve Vucic; Graeme Stewart; Andrew F Bleasel; David Booth; Victor S C Fung; Russell C Dale; Fabienne Brilot
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.